US FDA Likely To Embrace In-Person, Remote Combo For Facility Inspections Going Forward
Executive Summary
You may also be interested in...
In-Person US FDA Meetings Returning? Agency Will Support Those Events At HQ
A workshop broadcast from White Oak was a shift from the fully virtual meetings held since the height of the COVID-19 pandemic and may be a step toward once again staging public events there.
US FDA Raises Problems With EU Data Protection Reg, But Are They Among Those Misunderstanding It?
An FDA blog post says some inspections have been hindered and application assessments soon could be delayed by the EU General Data Protection Regulation (GDPR), but experts argue the law includes directions to allow data sharing and remain compliant.
Clinical Trials, Data Security Among US Federal Enforcement Priorities
Pandemic-related fraud, advertising to children, and corporate compliance programs are among the issues that were highlighted during a recent webinar.